Search results for "ALPHA"

showing 10 items of 3228 documents

Underexpressed Coactivators PGC1α AND SRC1 Impair Hepatocyte Nuclear Factor 4α Function and Promote Dedifferentiation in Human Hepatoma Cells

2006

Hepatocyte nuclear factor 4alpha (HNF4alpha) plays critical roles during liver development and in the transcriptional regulation of many hepatic genes in adult liver. Here we have demonstrated that in human hepatoma HepG2 cells, HNF4alpha is expressed at levels as high as in human liver but its activity on target genes is very low or absent. We have discovered that the low expression of key coactivators (PGC1alpha, SRC1, SRC2, and PCAF) might account for the lack of function of HNF4alpha in HepG2 cells. Among them, PGC1alpha and SRC1 are the two most important HNF4alpha coactivators as revealed by reporter assays with an Apo-CIII promoter construct. Moreover, the expression of these two coa…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularDown-RegulationBiologyBiochemistryNuclear Receptor Coactivator 1Cell Line TumorInternal medicinemedicineTranscriptional regulationHomeostasisHumansMolecular BiologyPsychological repressionHeat-Shock ProteinsAgedHistone AcetyltransferasesLiver NeoplasmsCell DifferentiationCell BiologyMiddle AgedPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhenotypeCell biologyNuclear receptor coactivator 1Hepatocyte nuclear factorsEndocrinologyHepatocyte Nuclear Factor 4LiverPCAFCell cultureFemaleHomeostasisTranscription FactorsJournal of Biological Chemistry
researchProduct

Five-Year Survival After Monotherapy for Hepatocellular Carcinoma in the Setting of Cirrhosis

2008

The purpose of this study was to evaluate the long-term results with monotherapy for hepatocellular carcinoma (HCC) in the setting of cirrhosis. We reviewed data of 14 patients who survived for at least 5 years after performance of liver resection (n = 1), transarterial chemoembolization (TACE, n = 3), or liver transplantation (OLT, n = 19). Eight patients were within the Milan criteria, whereas the remaining 6 were beyond the criteria. Tumor stages according to the UICC were I (n = 8), II (n = 5), and IIIA (n = 1). Vascular invasion was not detected in any patient. The HCCs recurred in 2 patients, at 81 and 48 months' posttransplant. Sites of recurrence were the intrathoracic lymph nodes i…

AdultMalemedicine.medical_specialtyCarcinoma HepatocellularTime FactorsCirrhosismedicine.medical_treatmentMedizinMilan criteriaLiver transplantationGastroenterologyInternal medicinemedicineCarcinomaHumansSurvivorsChemoembolization TherapeuticSurvival rateAgedTransplantationbusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseaseLiver TransplantationSurgerySurvival RateTransplantationHepatocellular carcinomaFemaleSurgeryalpha-FetoproteinsNeoplasm Recurrence LocalbusinessLiver cancerFollow-Up StudiesTransplantation Proceedings
researchProduct

Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity

2021

Abstract Background and aims Obesity is a key contributing factor to incidental type 2 diabetes and cardiovascular disease. CXCR3 receptor and its ligands CXCL 10 and 11 are associated with atherosclerosis and cardiovascular disease. The aim of our study was to analyse the role of the CXCR3 ligands on insulin resistance (IR) and endothelial dysfunction in human obesity. Methods and results We have studied 45 obese patients (mean age 44 ± 6 years, body mass index 45 ± 9 kg/m2) who were selected for Roux-Y-gastric bypass surgery and 21 non obese control subjects with similar age and gender distribution. We measured by ELISA the circulating levels of the CXCR3 ligands interferon-γ inducible pr…

AdultMalemedicine.medical_specialtyChemokineReceptors CXCR3Type 2 diabetesCXCR3BiochemistryInsulin resistanceInternal medicineCell AdhesionLeukocytesmedicineHumansCXCL10CXCL11ObesityEndothelial dysfunctionCells CulturedbiologyTumor Necrosis Factor-alphabusiness.industryEndothelial CellsCell BiologyMiddle Agedmedicine.diseaseChemokine CXCL11Up-RegulationChemokine CXCL10EndocrinologyCase-Control Studiesbiology.proteinFemaleInsulin ResistanceCardiology and Cardiovascular MedicinebusinessBody mass indexSignal TransductionMicrovascular Research
researchProduct

Transfusion-associated chronic hepatitis C: alpha-n1 interferon for 6 vs. 12 months.

1996

Abstract Aims: To compare the long-term effects of brief and prolonged therapy with alpha-n 1 interferon for transfusion-associated chronic hepatitis C. Methods: One hundred and sixteen subjects (male/female 4868, mean age 46.9 years) were studied. Sixty patients were randomised to brief treatment (group 1: interferon 5 Mu/msq. t.i.w. for 2 months, then 3 Mu/msq. t.i.w. for 4 months), and 56 to prolonged treatment (group 2: interferon 5 Mu/msq. t.i.w. for 2 months, then 3 Mu/msq. t.i.w. for 10 months). All were followed for 12 months after stopping interferon. Results: The early response rate was 47.4% (Group 1 [45%], Group 2 [50%]). No "breakthrough" reactivations were observed. The early …

AdultMalemedicine.medical_specialtyCirrhosisAdolescentmedicine.medical_treatmentHepatitis C virusPopulationAlpha interferonmedicine.disease_causeGastroenterologyAntibodiesDrug Administration ScheduleInterferonInternal medicinemedicineHumanseducationInterferon alfaAgededucation.field_of_studyHepatologybusiness.industryInterferon-alphaTransfusion ReactionImmunotherapyMiddle Agedmedicine.diseaseHepatitis CSurgeryChronic DiseaseFemalebusinessComplicationmedicine.drugJournal of hepatology
researchProduct

The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans

2003

Background: Purpose of this study was to investigate the functional relationship between electroencephalographic (EEG) alpha power and cerebral glucose metabolism before and after pharmacological alpha suppression by lorazepam. Methods: Ten healthy male volunteers were examined undergoing two F18-fluorodeoxyglucose (18-FDG) positron emission tomography (PET) scans with simultaneous EEG recording: 1× placebo, 1× lorazepam. EEG power spectra were computed by means of Fourier analysis. The PET data were analyzed using SPM99, and the correlations between metabolism and alpha power were calculated for both conditions. Results: The comparison lorazepam versus placebo revealed reduced glucose meta…

AdultMalemedicine.medical_specialtyCognitive NeuroscienceThalamusPosterior parietal cortexAlpha (ethology)Sensory systemElectroencephalographyLorazepamThalamusParietal LobeCortex (anatomy)Internal medicinemental disordersmedicineHumansModels Statisticalmedicine.diagnostic_testParietal lobeBrainMiddle AgedAlpha RhythmGlucosemedicine.anatomical_structureAnti-Anxiety AgentsNeurologyAnesthesiaCardiologyOccipital LobeOccipital lobePsychologyTomography Emission-ComputedNeuroImage
researchProduct

Perceiving numbers alters time perception.

2008

The representation of time, space and numbers are strictly linked in the primate's cognitive system. Here we show that merely looking at number symbols biases a temporal judgment on their duration depending upon the number's magnitude. In a first experiment, a group of healthy subjects was submitted to a time estimation task, requiring to judge whether the duration of a test stimulus was longer or shorter than that of a previous reference fixed stimulus (digit 5; duration 300 ms). Test stimuli were the digits 1, 5 and 9 ranging between 250 and 350 ms. The main results showed that temporal perception was biased according to the magnitude expressed by the digit: low digits (i.e. 1) leading to…

AdultMalemedicine.medical_specialtyCognitive systemsTime Factorsmedia_common.quotation_subjectAudiologyStimulus (physiology)Developmental psychologyNOTime estimationPerceptionmedicineHumansmedia_commonAnalysis of VarianceGeneral NeuroscienceHealthy subjectsTime perception numbers magnitudeTime perceptionPhotic Stimulation; Analysis of Variance; Humans; Adult; Time Perception; Time Factors; Male; Female; MathematicsNumerical digitTime PerceptionMagnitude Numbers Time perception Adult Analysis of Variance Female Humans Male Photic Stimulation Time Factors Time Perception Mathematics Neuroscience (all)Settore MED/26 - NeurologiaFemaleAlphabetPsychologyMathematicsPhotic StimulationNeuroscience letters
researchProduct

Maximal Strength, Muscular Endurance and Inflammatory Biomarkers in Young Adult Men

2014

The aim was to study associations of maximal strength and muscular endurance with inflammatory biomarkers independent of cardiorespiratory fitness in those with and without abdominal obesity. 686 young healthy men participated (25±5 years). Maximal strength was measured via isometric testing using dynamo-meters to determine maximal strength index. Muscular endurance index consisted of push-ups, sit-ups and repeated squats. An indirect cycle ergometer test until exhaustion was used to estimate maximal aerobic capacity (VO2max). Participants were stratified according to those with (102 cm) and those without abdominal obesity (102 cm) based on waist circumference. Inflammatory factors (C-react…

AdultMalemedicine.medical_specialtyCross-sectional studyPhysical Therapy Sports Therapy and RehabilitationIsometric exercise030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicinemedicineHumansOrthopedics and Sports MedicineMuscle Strength030212 general & internal medicineYoung adultAbdominal obesitybiologyInterleukin-6Tumor Necrosis Factor-alphabusiness.industryC-reactive proteinVO2 maxCardiorespiratory fitnessmedicine.diseaseObesityC-Reactive ProteinCross-Sectional StudiesPhysical FitnessObesity AbdominalPhysical EndurancePhysical therapybiology.proteinWaist Circumferencemedicine.symptombusinessBiomarkersInternational Journal of Sports Medicine
researchProduct

Prevalence of burnout in Polish anesthesiologists and anesthetist nursing professionals: A comparative non-randomized cross-sectional study.

2015

The purpose of the study was to assess the burnout levels in nurses ( N = 161) versus physicians ( N = 373). The levels of burnout were evaluated by the Polish adaptation of the Spanish Burnout Inventory (Cronbach’s alpha > .70). High burnout level was found in 18.63 percent nurses and 12.06 percent anesthesiologists, and critical level in 3.74 percent nurses and 5.90 percent anesthetists. There were statistically significant differences in Burnout global score, Enthusiasm toward the job, Psychological exhaustion, and Indolence subscales between nurses and physicians. No significant differences were found between sexes in any variable.

AdultMalemedicine.medical_specialtyCross-sectional studyhealth care facilities manpower and serviceseducationBurnout03 medical and health sciences0302 clinical medicineCronbach's alphaNursinghealth services administrationAnesthesiology0502 economics and businessPrevalenceMedicineHumans030212 general & internal medicineBurnout ProfessionalApplied PsychologyNurse AnesthetistsPsychiatric Status Rating Scalesbusiness.industry05 social sciencesNurse anesthetistMiddle AgedhumanitiesAnesthesiologistsCritical levelCross-Sectional StudiesFamily medicinePsychiatric status rating scalesFemalePolandbusinessbusiness.employerpsychological phenomena and processes050203 business & managementJournal of health psychology
researchProduct

Fabry disease: overall effects of agalsidase alfa treatment

2004

Background  Fabry disease is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. Progressive accumulation of the substrate globotriaosylceramide in cells throughout the body leads to major organ failure and premature death. The Fabry Outcome Survey (FOS) is a European outcomes database which was established to collect data on the natural history of this little-known disease and to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. This paper presents the first analysis of the FOS database on the effects of ERT on renal function, heart size, pain and quality of life. Design  The effects of 1 and 2 y…

AdultMalemedicine.medical_specialtyDatabases FactualClinical BiochemistryGlobotriaosylceramidePainRenal functionBiochemistrychemistry.chemical_compoundQuality of lifeInternal medicineHumansMedicineEnlarged heartBrief Pain Inventorybusiness.industryVascular diseaseMyocardiumGeneral MedicineEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryIsoenzymesTreatment Outcomechemistryalpha-GalactosidaseQuality of LifeFabry DiseaseFemaleHypertrophy Left VentricularbusinessFollow-Up StudiesGlomerular Filtration RateEuropean Journal of Clinical Investigation
researchProduct

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study

2018

Background The addition of an immunosuppressant (IM) after loss of response to anti-TNFα monotherapy is an emerging strategy of therapeutic optimization in patients with inflammatory bowel disease (IBD). However, few clinical data have been reported to date. We aimed to evaluate the efficacy and safety of this selective combination therapy in patients with IBD. Methods All consecutive patients with loss of response to anti-TNFα monotherapy despite an intensive dose optimization who added an IM from October 2014 to October 2016 were entered into a prospective database. Results Among 630 patients treated with anti-TNFα agents during the study period, 46 (7.3%) added an IM. A total of 31 patie…

AdultMalemedicine.medical_specialtyDatabases FactualCombination therapyGastroenterologyInflammatory bowel diseaseDrug Administration Schedule03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdalimumabHumansImmunology and AllergyProspective StudiesAdverse effectbiologyTumor Necrosis Factor-alphabusiness.industryRemission InductionC-reactive proteinAdalimumabGastroenterologyAntibodies MonoclonalMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseInfliximabGolimumabInfliximabDiscontinuationC-Reactive ProteinTreatment Outcome030220 oncology & carcinogenesisbiology.proteinDrug Therapy CombinationFemale030211 gastroenterology & hepatologybusinessImmunosuppressive Agentsmedicine.drugInflammatory Bowel Diseases
researchProduct